These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28963545)

  • 21. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
    Osborn JA; Yu C; Stelzl GE; Weinberg J
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concordant pattern of the HPA axis response to visceral stimulation and CRH administration.
    Yagihashi M; Kano M; Muratsubaki T; Morishita J; Kono K; Tanaka Y; Kanazawa M; Fukudo S
    Neurosci Res; 2021 Jul; 168():32-40. PubMed ID: 33785411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA; Belz EE; Czambel RK; Rubin RT; Rhodes ME
    J Pharmacol Toxicol Methods; 2006; 53(3):264-71. PubMed ID: 16311047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.
    Muglia LJ; Jacobson L; Luedke C; Vogt SK; Schaefer ML; Dikkes P; Fukuda S; Sakai Y; Suda T; Majzoub JA
    J Clin Invest; 2000 May; 105(9):1269-77. PubMed ID: 10792002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?
    Dinan TG; Quigley EM; Ahmed SM; Scully P; O'Brien S; O'Mahony L; O'Mahony S; Shanahan F; Keeling PW
    Gastroenterology; 2006 Feb; 130(2):304-11. PubMed ID: 16472586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
    Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes.
    Neumann ID; Johnstone HA; Hatzinger M; Liebsch G; Shipston M; Russell JA; Landgraf R; Douglas AJ
    J Physiol; 1998 Apr; 508 ( Pt 1)(Pt 1):289-300. PubMed ID: 9490853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress and visceral pain: focusing on irritable bowel syndrome.
    Fukudo S
    Pain; 2013 Dec; 154 Suppl 1():S63-S70. PubMed ID: 24021863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parasympathetic activity correlates with subjective and brain responses to rectal distension in healthy subjects but not in non-constipated patients with irritable bowel syndrome.
    Kano M; Yoshizawa M; Kono K; Muratsubaki T; Morishita J; Van Oudenhove L; Yagihashi M; Mugikura S; Dupont P; Takase K; Kanazawa M; Fukudo S
    Sci Rep; 2019 May; 9(1):7358. PubMed ID: 31089154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamo-pituitary-adrenal axis sensitization after chronic salt loading.
    Amaya F; Tanaka M; Hayashi S; Tanaka Y; Ibata Y
    Neuroendocrinology; 2001 Mar; 73(3):185-93. PubMed ID: 11307037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.
    Kamilaris TC; Johnson EO; Calogero AE; Kalogeras KT; Bernardini R; Chrousos GP; Gold PW
    Endocrinology; 1992 Apr; 130(4):1764-74. PubMed ID: 1312423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified dexamethasone suppression-corticotropin-releasing hormone stimulation test: A pilot study of young healthy volunteers and implications for alcoholism research in adolescents and young adults.
    Sher L; Cooper TB; Mann JJ; Oquendo MA
    Int J Adolesc Med Health; 2006; 18(1):133-7. PubMed ID: 16639867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal symptoms are associated with hypothalamic-pituitary-adrenal axis suppression in healthy individuals.
    Karling P; Norrback KF; Adolfsson R; Danielsson A
    Scand J Gastroenterol; 2007 Nov; 42(11):1294-301. PubMed ID: 17852841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response.
    Orand A; Naliboff B; Gadd M; Shih W; Ju T; Presson AP; Mayer EA; Chang L
    Psychoneuroendocrinology; 2016 Nov; 73():133-141. PubMed ID: 27497153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
    Kent P; Anisman H; Merali Z
    Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C; Iyer V; Bhatnagar S
    J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.